17-alpha-hydroxyprogesterone has been researched along with Growth Disorders in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (33.33) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adiyaman, P; Aycan, Z; Berberoglu, M; Cetinkaya, E; Evliyaoglu, O; Ocal, G | 1 |
| Gunzcler, P; Kuhnle, U; Levine, LS; New, MI; Pareira, JA; Rösler, A | 1 |
| Cunha, CF; Kater, CE; Silva, IN; Viana, MB | 1 |
| Ercan, O; Hatemi, S; Kutlu, E; Turan, N | 1 |
| Nishi, Y; Tezuka, T | 1 |
| Chrousos, GP; Feuillan, P; Linder, B | 1 |
1 trial(s) available for 17-alpha-hydroxyprogesterone and Growth Disorders
| Article | Year |
|---|---|
Randomised controlled trial of growth effect of hydrocortisone in congenital adrenal hyperplasia.
Topics: 17-alpha-Hydroxyprogesterone; Adolescent; Adrenal Hyperplasia, Congenital; Androstenedione; Body Height; Child; Child, Preschool; Cross-Over Studies; Dose-Response Relationship, Drug; Female; Growth Disorders; Humans; Hydrocortisone; Infant; Male; Mixed Function Oxygenases; Prospective Studies; Testosterone | 1997 |
5 other study(ies) available for 17-alpha-hydroxyprogesterone and Growth Disorders
| Article | Year |
|---|---|
Experience with long-term glucocorticoid treatment in congenital adrenal hyperplasia: growth pattern compared with genetic height potential.
Topics: 17-alpha-Hydroxyprogesterone; Adrenal Hyperplasia, Congenital; Adrenocorticotropic Hormone; Age Determination by Skeleton; Anthropometry; Body Height; Child; Child, Preschool; Female; Follow-Up Studies; Growth Disorders; Hormone Replacement Therapy; Humans; Hydrocortisone; Infant; Longitudinal Studies; Male; Statistics, Nonparametric | 2006 |
The effects of long-term normalization of sodium balance on linear growth in disorders with aldosterone deficiency.
Topics: 17-alpha-Hydroxyprogesterone; Addison Disease; Adolescent; Adrenal Hyperplasia, Congenital; Aldosterone; Child; Female; Follow-Up Studies; Growth Disorders; Humans; Hydroxyprogesterones; Male; Mineralocorticoids; Renin; Sodium; Time Factors; Water-Electrolyte Balance | 1983 |
Effect of treatment on growth in congenital adrenal hyperplasia.
Topics: 17-alpha-Hydroxyprogesterone; Adolescent; Adrenal Hyperplasia, Congenital; Age Determination by Skeleton; Body Height; Child; Child, Preschool; Female; Glucocorticoids; Growth; Growth Disorders; Humans; Infant; Male; Prednisolone; Prognosis; Retrospective Studies | 2000 |
Mild adrenal 3 beta-hydroxysteroid dehydrogenase deficiency in children with accelerated growth, premature pubarche and/or hirsutism.
Topics: 17-alpha-Hydroxypregnenolone; 17-alpha-Hydroxyprogesterone; 3-Hydroxysteroid Dehydrogenases; Adolescent; Adrenocorticotropic Hormone; Age Determination by Skeleton; Androstenedione; Child; Dehydroepiandrosterone; Dexamethasone; Female; Growth Disorders; Hirsutism; Humans; Hydroxyprogesterones; Male; Sexual Maturation; Testosterone | 1992 |
Alternate day prednisone therapy in congenital adrenal hyperplasia: adrenal androgen suppression and normal growth.
Topics: 17-alpha-Hydroxyprogesterone; Adrenal Glands; Adrenal Hyperplasia, Congenital; Adrenocorticotropic Hormone; Androgens; Androstenedione; Child; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Drug Administration Schedule; Female; Growth Disorders; Humans; Hydroxyprogesterones; Prednisone | 1989 |